Literature DB >> 12403741

Should combination therapy with inhaled corticosteroids and long-acting beta2-agonists be prescribed as initial maintenance treatment for asthma?

Catherine Lemière1, Allan Becker, Louis-Philippe Boulet, Dennis Bowie, André Cartier, Donald Cockroft, Robert Cowie, Pierre Ernst, Mark Fitzgerald, Malcolm Sears, Sheldon Spier.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12403741      PMCID： PMC134178     

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  5 in total

1.  Low dose inhaled budesonide and formoterol in mild persistent asthma: the OPTIMA randomized trial.

Authors:  P M O'Byrne; P J Barnes; R Rodriguez-Roisin; E Runnerstrom; T Sandstrom; K Svensson; A Tattersfield
Journal:  Am J Respir Crit Care Med       Date:  2001-10-15       Impact factor: 21.405

Review 2.  Canadian Asthma Consensus Report, 1999. Canadian Asthma Consensus Group.

Authors:  L P Boulet; A Becker; D Bérubé; R Beveridge; P Ernst
Journal:  CMAJ       Date:  1999-11-30       Impact factor: 8.262

3.  Meta-analysis of increased dose of inhaled steroid or addition of salmeterol in symptomatic asthma (MIASMA).

Authors:  S Shrewsbury; S Pyke; M Britton
Journal:  BMJ       Date:  2000-05-20

4.  Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group.

Authors:  R A Pauwels; C G Löfdahl; D S Postma; A E Tattersfield; P O'Byrne; P J Barnes; A Ullman
Journal:  N Engl J Med       Date:  1997-11-13       Impact factor: 91.245

5.  Addition of salmeterol to low-dose fluticasone versus higher-dose fluticasone: an analysis of asthma exacerbations.

Authors:  J Matz; A Emmett; K Rickard; C Kalberg
Journal:  J Allergy Clin Immunol       Date:  2001-05       Impact factor: 10.793
  5 in total
  6 in total

1.  Drug marketing: unsafe at any dose?

Authors: 
Journal:  CMAJ       Date:  2002-10-29       Impact factor: 8.262

Review 2.  Diagnosis of asthma in adults.

Authors:  Alan G Kaplan; Meyer S Balter; Alan D Bell; Harold Kim; R Andrew McIvor
Journal:  CMAJ       Date:  2009-09-21       Impact factor: 8.262

3.  Canadian Thoracic Society Asthma Management Continuum--2010 Consensus Summary for children six years of age and over, and adults.

Authors:  M D Lougheed; C Lemière; S D Dell; F M Ducharme; J Mark Fitzgerald; R Leigh; C Licskai; B H Rowe; D Bowie; A Becker; Louis-Philippe Boulet
Journal:  Can Respir J       Date:  2010 Jan-Feb       Impact factor: 2.409

Review 4.  Salmeterol (Serevent) asthma trial halted early.

Authors:  Eric Wooltorton
Journal:  CMAJ       Date:  2003-03-18       Impact factor: 8.262

Review 5.  Long-acting beta 2-adrenoceptor agonists and exercise-induced asthma: lessons to guide us in the future.

Authors:  Sandra D Anderson; John D Brannan
Journal:  Paediatr Drugs       Date:  2004       Impact factor: 3.022

6.  Combination fixed-dose beta agonist and steroid inhaler as required for adults or children with mild asthma.

Authors:  Iain Crossingham; Sally Turner; Sanjay Ramakrishnan; Anastasia Fries; Matthew Gowell; Farhat Yasmin; Rebekah Richardson; Philip Webb; Emily O'Boyle; Timothy Sc Hinks
Journal:  Cochrane Database Syst Rev       Date:  2021-05-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.